 |
 |
|
|
|
| Imidafenacin |
 |
| 4-(2-Methyl-1H-imidazolyl-1-yl)-2,2-diphenylbutyramide |
 |
| 170105-16-5 |
 |
| Imidafenacin is an orally-active anticholinergic agent with muscarinic M1 and M3 activity, developed by Kyorin for the treatment of urinary incontinence. It may have fewer side-effects such as dry mouth |
 |
DESCRIPTION WHITE TO OFF-WHITE POWDER
IDENTIFICATION IR./HPLC: CONFORMS
MELTING POINT 188 ~ 191℃
LOSS ON DRYING NOT MORE THAN 0.5%
RESIDUE ON IGNITION NOT MORE THAN 0.1%
HEAVY METALS NOT MORE THAN 20PPM
RELATED SUBSTANCES TOTAL IMPURITIES: NOT MORE THAN 1%
ASSAY (HPLC)
(ON DRIED BASIS) NOT LESS THAN 98.0% (C20H21N3O)
|
|
|
|
|
|
